Shanghai Shyndec Pharmaceutical Co., Ltd. (SHA: 600420)
China flag China · Delayed Price · Currency is CNY
12.28
-0.19 (-1.52%)
Nov 15, 2024, 3:00 PM CST

Shanghai Shyndec Pharmaceutical Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Cash & Equivalents
5,6405,9736,1484,2843,7205,164
Upgrade
Cash & Short-Term Investments
5,6405,9736,1484,2843,7205,164
Upgrade
Cash Growth
0.31%-2.86%43.51%15.18%-27.97%34.92%
Upgrade
Accounts Receivable
1,7042,0512,6563,0482,6021,764
Upgrade
Other Receivables
91.484.0792.8596.91108.01113.24
Upgrade
Receivables
1,7952,1352,7483,1442,7101,877
Upgrade
Inventory
2,2202,2802,4403,0723,2812,318
Upgrade
Prepaid Expenses
-61.6347.6940.2154.9583.46
Upgrade
Other Current Assets
1,943207.49300.4345.15396.54233.58
Upgrade
Total Current Assets
11,59810,65711,68410,88610,1629,676
Upgrade
Property, Plant & Equipment
5,6195,8856,2466,5116,4096,248
Upgrade
Long-Term Investments
383.251,431376.22370.77382.29192.42
Upgrade
Goodwill
160.15160.15160.15160.15292.3337.05
Upgrade
Other Intangible Assets
556.36511.18517.08549.09524.58533.66
Upgrade
Long-Term Deferred Tax Assets
133.97153.13239.09188.75115.32122.44
Upgrade
Long-Term Deferred Charges
372331.74227.83144.74169.53187.3
Upgrade
Other Long-Term Assets
1,244223.65179.17259.22195.05341.44
Upgrade
Total Assets
20,06619,35219,63019,07018,25017,638
Upgrade
Accounts Payable
1,4131,3741,2491,5422,1051,369
Upgrade
Accrued Expenses
278.051,5951,6751,670468.15411.92
Upgrade
Short-Term Debt
50.0945.05321.142,0141,6192,064
Upgrade
Current Portion of Long-Term Debt
1,032-48.37539.63144.99729.58
Upgrade
Current Portion of Leases
-10.69.8640.1349.4185.29
Upgrade
Current Income Taxes Payable
109.3729.9537.9430.8623.8444.74
Upgrade
Current Unearned Revenue
182.33244.6344.17201.231,362-
Upgrade
Other Current Liabilities
1,554480.59509.97804.25422.991,687
Upgrade
Total Current Liabilities
4,6183,7804,1966,8436,1946,492
Upgrade
Long-Term Debt
-1,0312,9551,5471,9881,647
Upgrade
Long-Term Leases
49.957.9768.57430.5944.51
Upgrade
Long-Term Unearned Revenue
124.24122.8138.01140.33167.03169.18
Upgrade
Long-Term Deferred Tax Liabilities
80.2322.15119.55126.1980.3181.44
Upgrade
Total Liabilities
4,8735,0147,4788,7008,4318,435
Upgrade
Common Stock
1,3411,3411,1721,0271,0271,027
Upgrade
Additional Paid-In Capital
5,2045,2043,5872,5452,5452,545
Upgrade
Retained Earnings
6,5315,8455,2874,7624,3003,757
Upgrade
Comprehensive Income & Other
-1.2-1.09259.34258.88258.63258.63
Upgrade
Total Common Equity
13,07512,38810,3058,5938,1317,587
Upgrade
Minority Interest
2,1191,9501,8471,7771,6881,616
Upgrade
Shareholders' Equity
15,19314,33812,15310,3709,8199,203
Upgrade
Total Liabilities & Equity
20,06619,35219,63019,07018,25017,638
Upgrade
Total Debt
1,1321,1453,4034,1843,8024,671
Upgrade
Net Cash (Debt)
4,5094,8282,74599.84-82.31493.4
Upgrade
Net Cash Growth
0.53%75.90%2649.36%---45.57%
Upgrade
Net Cash Per Share
3.363.792.370.08-0.070.43
Upgrade
Filing Date Shares Outstanding
1,3411,3411,1721,0271,0271,027
Upgrade
Total Common Shares Outstanding
1,3411,3411,1721,0271,0271,027
Upgrade
Working Capital
6,9806,8777,4894,0443,9683,185
Upgrade
Book Value Per Share
9.759.248.578.117.927.39
Upgrade
Tangible Book Value
12,35811,7179,6287,8847,3146,717
Upgrade
Tangible Book Value Per Share
9.218.747.997.427.126.54
Upgrade
Buildings
-4,4723,9453,8743,7123,577
Upgrade
Machinery
-8,3708,1847,9207,4286,762
Upgrade
Construction In Progress
-101.35642.37585.52575.85580.07
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.